(CNS) control group also presents some problems. Their CNS control group consisted of
patients with cerebrovascular disease (CVD) and patients with neurodegenerative diseases …

Recently, decreased accumulation of cardiac MIBG in patients with Parkinson's disease has
been reported, and researchers have suspected that the involvement of ganglionic and …

{sup 123} I-metaiodobenzylguanidine (MIBG) is an analog of norepinephrine and a tracer for
sympathetic neuron integrity and function. MIBG myocardial scintigraphy was performed in …

Methods: We studied35 patientswith Parkinson'sdisease and 24 control subjects with other
central nervous system diseases. The latter group consisted of 12 subjects with other …

1984 Objectives We examined the relations between myocardial MIBG uptake and severity
of disease in patients with idiopathic Parkinson's disease. Methods 123I …

Second, authorship credit should reflect substantial contributions to the study (3). Although
the number of authors of the Japanese version (2) is 3, the English version (1) appears to …

A 72-year-old woman with Parkinson's disease and autonomic dysfunction underwent I-123
MIBG cardiac imaging to study sympathetic neuronal integrity. This revealed a defect in the …

Second, authorship credit should reflect substantial contributions to the study (3). Although
the number of authors of the Japanese version (2) is 3, the English version (1) appears to …

Decreased cardiac uptake in 123I-metaiodobenzylguanidine (MIBG) scintigraphy has been
adopted as one of the most reliable diagnostic tests for Parkinson disease (PD) in Japan. To …

Background Decreased cardiac metaiodobenzylguanidine (MIBG) uptake was reported in
Parkinson's disease and this contributes to the differential diagnosis between Parkinson's …